Temporal trends in the progression of human immunodeficiency virus disease in a cohort of drug users

Mayris P. Webber, Ellie Schoenbaum, Marc N. Gourevitch, Donna Buono, Chee Jen Chang, Robert S. Klein

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We evaluated changes over time in rates of progression to AIDS, mortality, and distribution of AIDS-defining illnesses in 524 human immunodeficiency virus (HIV)-seropositive injection drug users enrolled between 1986 and 1995 in a prospective study of HIV infection in the Bronx, NY. At enrollment, participants attended a hospital-affiliated methadone maintenance program with on-site primary care. Using the 1993 clinical definition of AIDS, we found that the hazard ratio (HR) of progression to AIDS declined for enrollees over time in comparison with the referent group of persons enrolled in 1986-1987. For program enrollees in 1988-1989, the HR was 1.0 [95% confidence interval (CI) = 0.6-1.6]; for enrollees in 1990- 1991, the HR was 0.3 (95% CI = 0.1-0.9); for enrollees in 1992-1993, the HR was 0.5 (95% CI = 0.3-0.9); and for enrollees in 1994-1995, the HR was 0.2 (95% CI = 0.1-0.7), after controlling on initial CD4+ cell counts and age. Nevertheless, the greater AIDS-free time of later study entrants was not associated with reduced mortality. The study provides evidence that drug users with access to primary care likely benefited from improved management of HIV disease in prolonging AIDS-free time but, through 1996, did not experience greater survival.

Original languageEnglish (US)
Pages (from-to)613-617
Number of pages5
JournalEpidemiology
Volume9
Issue number6
StatePublished - Nov 1998

Fingerprint

Virus Diseases
Drug Users
Acquired Immunodeficiency Syndrome
HIV
Confidence Intervals
Primary Health Care
Mortality
Methadone
CD4 Lymphocyte Count
Prospective Studies
Injections
Survival

Keywords

  • Injection drug users
  • Methadone maintenance
  • Primary care
  • Progression to AIDS

ASJC Scopus subject areas

  • Epidemiology

Cite this

Temporal trends in the progression of human immunodeficiency virus disease in a cohort of drug users. / Webber, Mayris P.; Schoenbaum, Ellie; Gourevitch, Marc N.; Buono, Donna; Chang, Chee Jen; Klein, Robert S.

In: Epidemiology, Vol. 9, No. 6, 11.1998, p. 613-617.

Research output: Contribution to journalArticle

Webber, Mayris P. ; Schoenbaum, Ellie ; Gourevitch, Marc N. ; Buono, Donna ; Chang, Chee Jen ; Klein, Robert S. / Temporal trends in the progression of human immunodeficiency virus disease in a cohort of drug users. In: Epidemiology. 1998 ; Vol. 9, No. 6. pp. 613-617.
@article{b743c6a29a7f4e0982d94b478e1da613,
title = "Temporal trends in the progression of human immunodeficiency virus disease in a cohort of drug users",
abstract = "We evaluated changes over time in rates of progression to AIDS, mortality, and distribution of AIDS-defining illnesses in 524 human immunodeficiency virus (HIV)-seropositive injection drug users enrolled between 1986 and 1995 in a prospective study of HIV infection in the Bronx, NY. At enrollment, participants attended a hospital-affiliated methadone maintenance program with on-site primary care. Using the 1993 clinical definition of AIDS, we found that the hazard ratio (HR) of progression to AIDS declined for enrollees over time in comparison with the referent group of persons enrolled in 1986-1987. For program enrollees in 1988-1989, the HR was 1.0 [95{\%} confidence interval (CI) = 0.6-1.6]; for enrollees in 1990- 1991, the HR was 0.3 (95{\%} CI = 0.1-0.9); for enrollees in 1992-1993, the HR was 0.5 (95{\%} CI = 0.3-0.9); and for enrollees in 1994-1995, the HR was 0.2 (95{\%} CI = 0.1-0.7), after controlling on initial CD4+ cell counts and age. Nevertheless, the greater AIDS-free time of later study entrants was not associated with reduced mortality. The study provides evidence that drug users with access to primary care likely benefited from improved management of HIV disease in prolonging AIDS-free time but, through 1996, did not experience greater survival.",
keywords = "Injection drug users, Methadone maintenance, Primary care, Progression to AIDS",
author = "Webber, {Mayris P.} and Ellie Schoenbaum and Gourevitch, {Marc N.} and Donna Buono and Chang, {Chee Jen} and Klein, {Robert S.}",
year = "1998",
month = "11",
language = "English (US)",
volume = "9",
pages = "613--617",
journal = "Epidemiology",
issn = "1044-3983",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Temporal trends in the progression of human immunodeficiency virus disease in a cohort of drug users

AU - Webber, Mayris P.

AU - Schoenbaum, Ellie

AU - Gourevitch, Marc N.

AU - Buono, Donna

AU - Chang, Chee Jen

AU - Klein, Robert S.

PY - 1998/11

Y1 - 1998/11

N2 - We evaluated changes over time in rates of progression to AIDS, mortality, and distribution of AIDS-defining illnesses in 524 human immunodeficiency virus (HIV)-seropositive injection drug users enrolled between 1986 and 1995 in a prospective study of HIV infection in the Bronx, NY. At enrollment, participants attended a hospital-affiliated methadone maintenance program with on-site primary care. Using the 1993 clinical definition of AIDS, we found that the hazard ratio (HR) of progression to AIDS declined for enrollees over time in comparison with the referent group of persons enrolled in 1986-1987. For program enrollees in 1988-1989, the HR was 1.0 [95% confidence interval (CI) = 0.6-1.6]; for enrollees in 1990- 1991, the HR was 0.3 (95% CI = 0.1-0.9); for enrollees in 1992-1993, the HR was 0.5 (95% CI = 0.3-0.9); and for enrollees in 1994-1995, the HR was 0.2 (95% CI = 0.1-0.7), after controlling on initial CD4+ cell counts and age. Nevertheless, the greater AIDS-free time of later study entrants was not associated with reduced mortality. The study provides evidence that drug users with access to primary care likely benefited from improved management of HIV disease in prolonging AIDS-free time but, through 1996, did not experience greater survival.

AB - We evaluated changes over time in rates of progression to AIDS, mortality, and distribution of AIDS-defining illnesses in 524 human immunodeficiency virus (HIV)-seropositive injection drug users enrolled between 1986 and 1995 in a prospective study of HIV infection in the Bronx, NY. At enrollment, participants attended a hospital-affiliated methadone maintenance program with on-site primary care. Using the 1993 clinical definition of AIDS, we found that the hazard ratio (HR) of progression to AIDS declined for enrollees over time in comparison with the referent group of persons enrolled in 1986-1987. For program enrollees in 1988-1989, the HR was 1.0 [95% confidence interval (CI) = 0.6-1.6]; for enrollees in 1990- 1991, the HR was 0.3 (95% CI = 0.1-0.9); for enrollees in 1992-1993, the HR was 0.5 (95% CI = 0.3-0.9); and for enrollees in 1994-1995, the HR was 0.2 (95% CI = 0.1-0.7), after controlling on initial CD4+ cell counts and age. Nevertheless, the greater AIDS-free time of later study entrants was not associated with reduced mortality. The study provides evidence that drug users with access to primary care likely benefited from improved management of HIV disease in prolonging AIDS-free time but, through 1996, did not experience greater survival.

KW - Injection drug users

KW - Methadone maintenance

KW - Primary care

KW - Progression to AIDS

UR - http://www.scopus.com/inward/record.url?scp=0031697945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031697945&partnerID=8YFLogxK

M3 - Article

C2 - 9799169

AN - SCOPUS:0031697945

VL - 9

SP - 613

EP - 617

JO - Epidemiology

JF - Epidemiology

SN - 1044-3983

IS - 6

ER -